| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502370 | Journal of Geriatric Oncology | 2017 | 8 Pages |
Abstract
NEPA is highly effective in older patients receiving MEC or HEC regimens. NEPA is also well tolerated, demonstrating suitability for use in older patients who may have comorbidities.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Matti Aapro, Karin Jordan, Richard J. Gralla, Giada Rizzi, Giorgia Rossi, Marco Palmas, Anna V. Alyasova, Alla S. Lisyanskaya, Snežana M. Bošnjak, Paul J. Hesketh,